Elucidating the pan-oncologic landscape of S100A9: prognostic and therapeutic corollaries from an integrative bioinformatics and Mendelian randomization analysis.

Although the prognostic value of S100A9 expression was only marginally significant in several cancers, including breast cancer, S100A9 has been identified as a proto-oncogene in various malignancies, such as bladder, colorectal, and pancreatic cancers 30 .

also in 5,076 other papers